TrialAtlas: Multi-Agent Research Organization for Clinical Trial Design and Optimization
DGX agentarXiv:2609.21859v1 Announce Type: new Abstract: Nearly 90% of drugs entering clinical development ultimately fail, despite billions of dollars in investment. Pharmaceutical companies therefore rely on